T
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Toshali Pandey's research interests encompass the impact of the COVID-19 pandemic on medical training, the quality of life for patients with esophageal strictures, and the evaluation of immunohistochemistry techniques. Pandey has investigated the validity and reliability of quality of life questionnaires in specific patient populations and explored nutritional status in individuals with refractory corrosive-induced esophageal strictures. Additionally, Pandey has examined immunocytochemistry on destained Giemsa stained smears as an alternative to conventional methods. The researcher's work also touches upon immune cell profiling in response to CAR-T cell therapy for multiple myeloma, prediction of survival based on drug-induced rash after mogamulizumab administration, and risk factors for acute kidney injury in patients receiving CAR-T cells. Pandey has also contributed to understanding cardiotoxicity surveillance in targeted immunotherapy, particularly the role of cytokine release syndrome in detecting cancer therapy-related cardiac dysfunction after CAR-T therapy.
Metrics
- h-index: 2
- Publications: 17
- Citations: 7
Selected Publications
-
Peripheral blood immune cell profiling and response to BCMA CAR-T cell therapy in relapsed refractory multiple myeloma (2026)
-
Can the development of drug-induced rash after mogamulizumab administration predict survival in mycosis fungoides/sezary syndrome? a trinetx-based analysis (2025)
-
AKI in Patients Receiving Chimeric Antigen Receptor T Cells: Risk Factors and Characteristics (2025)
-
Revaccination status after bone marrow transplant and chimeric antigen receptor T-cell therapy. (2025)
-
Efficacy and safety of two-year fixed versus continuous immune checkpoint inhibitor therapy in advanced or metastatic non-small cell lung cancer: a systematic review (2025)
-
MRI lesion burden as a predictor of progression and survival in smoldering multiple myeloma. (2025)
-
Survival and safety of two year-fixed duration vs continuous immune checkpoint inhibitor therapy in advanced or metastatic NSCLC: A systematic review. (2025)
-
Chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma: a real-world experience (2025)
-
A Case Report on Pulmonary Tumor Embolism in a Patient With a Metastatic Gastrointestinal Stromal Tumor Invading the Inferior Vena Cava: Tumor or Thrombus? (2025)
-
Simultaneous Presentation of Relapsed Diffuse Large B-cell Lymphoma and Extrapulmonary Tuberculosis in a Patient With HIV: A Case Report (2025)
-
Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: A Real-World Experience (2024)
Collaboration Network
Top Collaborators
Bhavesh Mohan Lal
University of Arkansas for Medical Sciences
6 shared publications
In database
- Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: A Real-World Experience
- Chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma: a real-world experience
- MRI lesion burden as a predictor of progression and survival in smoldering multiple myeloma.
- Abstract 4358782: Redefining Cardiotoxicity Surveillance in Targeted Immunotherapy: Cytokine Release Syndrome as a High-Yield Trigger for Detecting Cancer Therapy-Related Cardiac Dysfunction After CAR-T Therapy
- AKI in Patients Receiving Chimeric Antigen Receptor T Cells: Risk Factors and Characteristics
Showing 5 of 6 shared publications
Carolina Schinke
University of Arkansas for Medical Sciences
4 shared publications
In database
- Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: A Real-World Experience
- Chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma: a real-world experience
- MRI lesion burden as a predictor of progression and survival in smoldering multiple myeloma.
- Peripheral blood immune cell profiling and response to BCMA CAR-T cell therapy in relapsed refractory multiple myeloma
Sharmilan Thanendrarajan
University of Arkansas for Medical Sciences
4 shared publications
In database
- Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: A Real-World Experience
- Chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma: a real-world experience
- MRI lesion burden as a predictor of progression and survival in smoldering multiple myeloma.
- Peripheral blood immune cell profiling and response to BCMA CAR-T cell therapy in relapsed refractory multiple myeloma
Ujjwal Sonika
Govind Ballabh Pant Hospital (IN)
3 shared publications
- Impact of the COVID-19 Pandemic on Gastroenterology Training in India
- Validity and Reliability of the European Organization Research and Treatment of Cancer Quality of Life Questionnaire-Oesophagogastric 25 in Indian Patients With Corrosive-Induced Benign Refractory Esophageal Strictures
- Quality of life and nutritional status of patients with refractory or recurrent corrosive-induced esophageal strictures on long-term endoscopic dilation
Sanjeev Sachdeva
Govind Ballabh Pant Hospital (IN)
3 shared publications
- Impact of the COVID-19 Pandemic on Gastroenterology Training in India
- Validity and Reliability of the European Organization Research and Treatment of Cancer Quality of Life Questionnaire-Oesophagogastric 25 in Indian Patients With Corrosive-Induced Benign Refractory Esophageal Strictures
- Quality of life and nutritional status of patients with refractory or recurrent corrosive-induced esophageal strictures on long-term endoscopic dilation
Ajay Kumar
Govind Ballabh Pant Hospital (IN)
3 shared publications
- Impact of the COVID-19 Pandemic on Gastroenterology Training in India
- Validity and Reliability of the European Organization Research and Treatment of Cancer Quality of Life Questionnaire-Oesophagogastric 25 in Indian Patients With Corrosive-Induced Benign Refractory Esophageal Strictures
- Quality of life and nutritional status of patients with refractory or recurrent corrosive-induced esophageal strictures on long-term endoscopic dilation
Siddharth Srivastava
Govind Ballabh Pant Hospital (IN)
3 shared publications
- Impact of the COVID-19 Pandemic on Gastroenterology Training in India
- Validity and Reliability of the European Organization Research and Treatment of Cancer Quality of Life Questionnaire-Oesophagogastric 25 in Indian Patients With Corrosive-Induced Benign Refractory Esophageal Strictures
- Quality of life and nutritional status of patients with refractory or recurrent corrosive-induced esophageal strictures on long-term endoscopic dilation
Barjesh Chander Sharma
Govind Ballabh Pant Hospital (IN)
3 shared publications
- Impact of the COVID-19 Pandemic on Gastroenterology Training in India
- Validity and Reliability of the European Organization Research and Treatment of Cancer Quality of Life Questionnaire-Oesophagogastric 25 in Indian Patients With Corrosive-Induced Benign Refractory Esophageal Strictures
- Quality of life and nutritional status of patients with refractory or recurrent corrosive-induced esophageal strictures on long-term endoscopic dilation
Ashok Dalal
Govind Ballabh Pant Hospital (IN)
3 shared publications
- Impact of the COVID-19 Pandemic on Gastroenterology Training in India
- Validity and Reliability of the European Organization Research and Treatment of Cancer Quality of Life Questionnaire-Oesophagogastric 25 in Indian Patients With Corrosive-Induced Benign Refractory Esophageal Strictures
- Quality of life and nutritional status of patients with refractory or recurrent corrosive-induced esophageal strictures on long-term endoscopic dilation
Marah Alzubi
3 shared publications
- Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: A Real-World Experience
- Chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma: a real-world experience
- Peripheral blood immune cell profiling and response to BCMA CAR-T cell therapy in relapsed refractory multiple myeloma
Jawad Alrawabdeh
University of Jordan (JO)
3 shared publications
- Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: A Real-World Experience
- Chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma: a real-world experience
- Peripheral blood immune cell profiling and response to BCMA CAR-T cell therapy in relapsed refractory multiple myeloma
Maurizio Zangari
University of Arkansas for Medical Sciences
3 shared publications
In database
- Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: A Real-World Experience
- Chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma: a real-world experience
- MRI lesion burden as a predictor of progression and survival in smoldering multiple myeloma.
Frits van Rhee
University of Arkansas for Medical Sciences
3 shared publications
In database
- Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: A Real-World Experience
- Chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma: a real-world experience
- MRI lesion burden as a predictor of progression and survival in smoldering multiple myeloma.
Samer Al Hadidi
University of Arkansas for Medical Sciences
3 shared publications
In database
- Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: A Real-World Experience
- Chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma: a real-world experience
- MRI lesion burden as a predictor of progression and survival in smoldering multiple myeloma.
Ankur Varma
University of Arkansas for Medical Sciences
3 shared publications
In database
- Simultaneous Presentation of Relapsed Diffuse Large B-cell Lymphoma and Extrapulmonary Tuberculosis in a Patient With HIV: A Case Report
- Revaccination status after bone marrow transplant and chimeric antigen receptor T-cell therapy.
- Can the development of drug-induced rash after mogamulizumab administration predict survival in mycosis fungoides/sezary syndrome? a trinetx-based analysis
Similar Researchers
Based on overlapping research topics
J Shaughnessy
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
CAR-T cell therapy research
Immune Cell Function and Interaction
April Clawson
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Cancer Treatment and Pharmacology
Molecular Biology Techniques and Applications
C.M. White
University of Arkansas – Fort Smith
SARS-CoV-2 and COVID-19 Research
Molecular Biology Techniques and Applications
Health Sciences Research and Education
Elsherbini, Medhat
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Molecular Biology Techniques and Applications
Health Sciences Research and Education
Pargam Vashishtha
University of Arkansas at Fayetteville
SARS-CoV-2 and COVID-19 Research
Molecular Biology Techniques and Applications
Health Sciences Research and Education
A. Mazin Safar
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Molecular Biology Techniques and Applications
Health Sciences Research and Education